Intellia Therapeutics, Inc. announced that John F. Crowley notified company of his intent to resign from the Board of Directors of the Company and its committees, effective December 5, 2023. Mr. Crowley currently serves on the Nominating and Governance Committee and on the Compensation and Talent Development Committee of the Board. His resignation is not the result of any disagreement with the Company on any matter relating to the Company?s operations, policies or practices.

The Company thanks Mr. Crowley for his long, dedicated service on the Board and wishes him well in his future pursuits.